WASHINGTON (AP) -- Government regulators have cleared the way for broader use of a blood test that can help heart transplant patients.
The test spares recipients the ordeal of repeated biopsies to check if their bodies are rejecting the new organ.
The FDA says the test, called AlloMap, is an example of how the science of genetics is changing the practice of medicine.
The test analyzes certain kinds of genetic information contained in white blood cells. Those are the cells that help the body fight off infections, but which can also turn against a donated organ with devastating effects.
The AlloMap test had been previously approved in 2005 under federal laws that govern clinical labs. FDA clearance should speed its adoption elsewhere.
(Copyright 2008 by The Associated Press. All Rights Reserved.)
KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.
If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.powered by Disqus